Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

2Total
P 1 (1)
P 3 (1)

Trial Status

Withdrawn1
Terminated1
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06019182Recruiting

MEHMO Natural History and Biomarkers

NCT00069329Phase 1TerminatedPrimary

Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease

NCT00301587Phase 3Withdrawn

A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives

Showing all 3 trials

Research Network

Activity Timeline